Literature DB >> 12729664

Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.

Franck Augé1, William Hornebeck, Martine Decarme, Jean-Yves Laronze.   

Abstract

The synthesis of several analogues of galardin, a MMP inhibitor, are presented with their in vitro inhibitory activity against MMP-1 and MMP-2. These compounds contain a distinct Zinc Binding Group (ZBG). Those having a 2-acylated-heterocycle as well as a 2-arylamide function do not exhibit a good inhibition/selectivity against the enzymes tested. On the contrary, those that are based on a hydrazide scaffold present potent selectivity for MMP-2 versus MMP-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729664     DOI: 10.1016/s0960-894x(03)00214-2

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Strategies to prevent hydrolytic degradation of the hybrid layer-A review.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2013-08-14       Impact factor: 5.304

3.  Use of a specific MMP-inhibitor (galardin) for preservation of hybrid layer.

Authors:  Lorenzo Breschi; Patrizia Martin; Annalisa Mazzoni; Fernando Nato; Marcela Carrilho; Leo Tjäderhane; Erika Visintini; Milena Cadenaro; Franklin R Tay; Elettra De Stefano Dorigo; David H Pashley
Journal:  Dent Mater       Date:  2010-03-17       Impact factor: 5.304

Review 4.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 6.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

7.  Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group.

Authors:  Etelka Farkas; Yiffat Katz; Sudhakar Bhusare; Reuven Reich; Gerd-Volker Röschenthaler; Martin Königsmann; Eli Breuer
Journal:  J Biol Inorg Chem       Date:  2004-02-05       Impact factor: 3.358

8.  Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders.

Authors:  Jérôme Jeanblanc; Erika Bourguet; Diana Sketriené; Céline Gonzalez; Gautier Moroy; Rémi Legastelois; Mathieu Létévé; Aurélie Trussardi-Régnier; Mickaël Naassila
Journal:  Psychopharmacology (Berl)       Date:  2018-04-30       Impact factor: 4.530

9.  Symmetry breaking of tissue mechanics in wound induced hair follicle regeneration of laboratory and spiny mice.

Authors:  Hans I-Chen Harn; Sheng-Pei Wang; Yung-Chih Lai; Ben Van Handel; Ya-Chen Liang; Stephanie Tsai; Ina Maria Schiessl; Arijita Sarkar; Haibin Xi; Michael Hughes; Stefan Kaemmer; Ming-Jer Tang; Janos Peti-Peterdi; April D Pyle; Thomas E Woolley; Denis Evseenko; Ting-Xin Jiang; Cheng-Ming Chuong
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

10.  Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.

Authors:  Jacob D Durrant; César Augusto F de Oliveira; J Andrew McCammon
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.